What's in Kinderkrankenhaus auf der Bult's pipeline?

Kinderkrankenhaus auf der Bult has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Kinderkrankenhaus auf der Bult's portfolio?

Top competitors by shared drug class: Biodel, DreaMed Diabetes, Eli Lilly and Company, Hospital Universitario Dr. Jose E. Gonzalez, Institute for Clinical and Experimental Medicine.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/kinderkrankenhaus-auf-der-bult.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Kinderkrankenhaus auf der Bult — Portfolio Competitive Intelligence Brief

Kinderkrankenhaus auf der Bult pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Apidra	Apidra	marketed		Insulin receptor	Metabolic
current insulin	current insulin	marketed	Insulin	Insulin receptor	Endocrinology / Diabetes

Therapeutic area mix

Endocrinology / Diabetes · 1
Metabolic · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Biodel · 1 shared drug class
DreaMed Diabetes · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
Hospital Universitario Dr. Jose E. Gonzalez · 1 shared drug class
Institute for Clinical and Experimental Medicine · 1 shared drug class
Mackay Memorial Hospital · 1 shared drug class
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 shared drug class
American Heart Association · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Kinderkrankenhaus auf der Bult:

Cite this brief

Drug Landscape (2026). Kinderkrankenhaus auf der Bult — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/kinderkrankenhaus-auf-der-bult. Accessed 2026-05-16.